PhytoSquene®

Bioresorbable polymers for controlled release depot injections & medical device applications.

The RESOMER® portfolio represents the industry’s leading selection of functional excipients for parenteral controlled release. As one of the global leaders at the market for custom and sp...

For more than 20 years, Evonik has been the world’s largest process developer and manufacturer of HPAPIs, with a total capacity of 170m³ and OEL down to 5 ng/m³. In addition to the development and implementation of highly potent API manufacturing processes for most classical organic reaction types, we exce...

Activated Alumina (aluminum oxide, CAS# 1344-28-1) for chromatography, batch extractions, decolorizations and more. Available in acidic, basic or neutral pHs, optimized particle size, surface area, pH, and purity make Chromatocel 150 series a particularly useful material for the separation of small molecul...

Silica gel (silicon dioxide, CAS# 112926-00-8) for chromatography, batch extractions, decolorizations and more. Optimized particle size, surface area, pH, and purity make Chromatocel S series a particularly useful material for the separation of small molecules, peptides, lipids, alkaloids, botanical extrac...

MaxiPure® Polysorbate 80 is a non-ionic surfactant. It is manufactured from highly pure oleic acid (≥98%), ensuring minimal impurities compared to standard grades. MaxiPure® Polysorbate 80 has reduced peroxide levels and water content, resulting in outstanding clarity.

In injectable formulations, Po...

Northern Lipids® is a brand that Evonik uses to represent the company's comprehensive lipid portfolio, which is a cornerstone in the market for advanced drug delivery systems. 

Evonik is a global leader in contract development and manufacturing (CDMO) services for lipid-based parenteral drug de...

EUDRACAPTM functional ready-to-fill capsules can optimize your release profile, protect your active ingredients, and help accelerate your speed to market. EUDRACAP™ is ideal for use with active ingredients which are sensitive to heat, moisture or gastric acid to optimize absorption and avoid premature ...

Evonik offers a new solubility enhancement technology and service package for small molecules used in oral drugs that are particularly challenging to dissolve. EUDRATEC® SoluFlow is the latest addition to Evonik’s platform of oral drug delivery technologies for targeted release. This process technology and...

Evonik is a global development partner and solutions provider for oral drug delivery. For more than 70 years, we have been providing renowned pharmaceutical and biotech companies with oral drug delivery solutions to help them enhance drug performance, reduce project complexity, increase speed to market and...

Noblyst® P products are precious metal powder catalysts on various support materials mostly used in batch and slurry processes. This brand also comprises a range designed for flow chemistry processes. Evonik provides a full service package, including precious metals management. With production sites in all...

Evonik is one of the world’s leading CDMOs for parenteral drug delivery. For complex parenteral drug products designed for systemic, targeted or localized delivery, we are uniquely positioned to serve as a global development partner and solutions provider. Our parenteral drug delivery portfolio includes th...

Plant-derived cholesterol for mRNA delivery, gene therapy and cell culture: Our plant-derived PhytoChol® provides you with a secure and stable supply of synthetic cholesterol. Evonik supplies PhytoChol® in two grades that are tailored to the specific needs of injectable drug delivery and biopharm...

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, which was held at CPHI Frankfurt, across the categories from digital innovation to CEO of the year. 

PhytoSquene® is the world’s first GMP-quality, plant-derived squalene. It offers a sustainable and high-quality alternative to traditional shark-derived squalene, meeting the need for sustainably sourced pharmaceutical-grade squalene. The key drivers behind its development are sustainability, safety, regulatory compliance and social responsibility. Extracting squalene from shark livers for use in parenteral pharmaceutical applications such as vaccines depletes shark populations, which impacts marine biodiversity. PhytoSquene® supports the UN Sustainable Development Goals (SDGs) of protecting ecosystems and promoting circularity, while also mitigating risks associated with bioaccumulative toxins found in animal sources, and ensuring batch-to-batch consistency and superior quality in compliance with European Pharmacopoeia standards. Made from amaranth oil and manufactured in Germany using proprietary technology, PhytoSquene® not only advances patient safety and acceptance, but also demonstrates Evonik’s commitment to next-generation solutions with a positive sustainability profile. PhytoSquene® provides vaccine manufacturers and patients peace of mind while protecting marine ecosystems.